November 13, 2019 11:00 am – November 13, 2019 1:00 pm (PST)
The Alexandria at Torrey Pines
10996 Torreyana Road
San Diego, CA 92121
Microbiome-based therapies have been a hot area of research for the last decade and promising early-stage therapies are in clinical development. While these are great opportunities in this space to address patients’ unmet medical needs, there are significant challenges associated with delivering microbiome derived therapies to patients.
During this session, speakers will reflect on the cross-functional opportunities and significant challenges they faced in early development of microbiome products in addition to discussing future milestones and anticipated obstacles along the way. Speakers will elucidate some of their significant learnings so far and share some of the unresolved hurdles in translating these therapies from research to clinical development. Attendees will receive a real-world perspective on the development of microbiome products from peers who have been in their shoes. Register here.
Stephanie Culler, PhD, Co-Founder and CEO, Persephone Biome
Will DeLoache, PhD, Co-Founder and CEO, Novome Biotechnologies
Jeanette Mucha, CEO, CSO, and Co-Founder, SciBac
Claudia Fehling, MPH (Moderator), Senior Consultant, Halloran Consulting Group
Anmol Grover, PhD (Moderator), Lead Consultant, Halloran Consulting Group